Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

SNY | Sanofi ADR

Healthcare | Drug Manufacturers - General | France | NASD

Index	-	P/E	15.04	EPS (ttm)	3.57	Insider Own	0.00%	Shs Outstand	2.51B	Perf Week	-0.70%
Market Cap	134.49B	Forward P/E	11.20	EPS next Y	4.79	Insider Trans	-	Shs Float	2.51B	Perf Month	-0.92%
Income	8.96B	PEG	2.16	EPS next Q	1.42	Inst Own	10.16%	Short Float / Ratio	0.15% / 2.96	Perf Quarter	-0.48%
Sales	45.33B	P/S	2.97	EPS this Y	-0.67%	Inst Trans	-1.66%	Short Interest	3.66M	Perf Half Y	-0.61%
Book/sh	31.66	P/B	1.69	EPS next Y	7.54%	ROA	6.79%	Target Price	61.54	Perf Year	40.53%
Cash/sh	3.48	P/C	15.42	EPS next 5Y	6.97%	ROE	11.68%	52W Range	37.53 - 57.82	Perf YTD	10.76%
Dividend	1.99	P/FCF	16.47	EPS past 5Y	15.72%	ROI	9.26%	52W High	-7.23%	Beta	0.56
Dividend %	3.71%	Quick Ratio	0.81	Sales past 5Y	2.74%	Gross Margin	62.86%	52W Low	42.93%	ATR	0.73
Employees	91573	Current Ratio	1.21	Sales Q/Q	-13.36%	Oper. Margin	22.55%	RSI (14)	48.72	Volatility	1.25% 1.14%
Optionable	Yes	Debt/Eq	0.29	EPS Q/Q	-	Profit Margin	19.77%	Rel Volume	3.19	Prev Close	53.01
Shortable	Yes	LT Debt/Eq	0.22	Earnings	Jul 28 BMO	Payout	39.20%	Avg Volume	1.24M	Price	53.64
Recom	1.96	SMA20	-0.49%	SMA50	0.26%	SMA200	3.91%	Volume	3,953,963	Change	1.19%

Date	Action	Analyst	Rating Change
Sep-06-23	Upgrade	Berenberg	Hold → Buy
Jul-14-23	Initiated	HSBC Securities	Buy
Apr-28-23	Downgrade	Deutsche Bank	Hold → Sell
Mar-27-23	Upgrade	Barclays	Equal Weight → Overweight
Dec-13-22	Resumed	Morgan Stanley	Overweight
Aug-12-22	Upgrade	Deutsche Bank	Sell → Hold
Aug-09-22	Downgrade	UBS	Buy → Neutral
May-23-22	Initiated	SVB Leerink	Outperform
Sep-27-21	Upgrade	SVB Leerink	Mkt Perform → Outperform
Jan-15-21	Initiated	Deutsche Bank	Sell
Sep-29-20	Initiated	Berenberg	Hold
Mar-17-20	Upgrade	Barclays	Underweight → Equal Weight
Mar-11-20	Upgrade	Goldman	Neutral → Buy
Feb-11-20	Initiated	SVB Leerink	Mkt Perform
Jan-06-20	Upgrade	JP Morgan	Neutral → Overweight
Sep-23-19	Upgrade	Guggenheim	Neutral → Buy
Sep-20-19	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-03-19	Initiated	Bernstein	Outperform
Aug-14-19	Upgrade	UBS	Neutral → Buy
Dec-11-18	Upgrade	Jefferies	Hold → Buy

Show Previous Ratings

Sep-29-23 09:28AM	Pharma Stock Roundup: FDA and EMA Regulatory Updates for ABBV, LLY, SNY & MRK's Drugs (Zacks)
Sep-27-23 03:48PM	Amazon Health: A long play and a search for partners (Yahoo Finance)
Sep-26-23 08:11AM	FDA Accepts Sanofi's (SNY) sBLA for Dupixent in Pediatric EoE (Zacks)
01:30AM	Press Release: Dupixent® (dupilumab) sBLA for treatment of eosinophilic esophagitis in children aged 1 to 11 accepted for FDA Priority Review (GlobeNewswire)
01:29AM	Dupixent® (dupilumab) sBLA for Treatment of Eosinophilic Esophagitis (EoE) in Children Aged 1 to 11 Accepted for FDA Priority Review (GlobeNewswire)
03:00AM	Loading…
Sep-25-23 03:00AM	Press Release: Once-weekly ALTUVIIIO® approved in Japan as a new class of factor VIII therapy for hemophilia A (GlobeNewswire)
Sep-22-23 06:50AM	Sanofi Anticipates Significant Hit to Q3 Earnings and Sales Due to Currency Fluctuations (Investing.com)
03:04AM	Sanofi Expects Currency Hit to Sales, Earnings (The Wall Street Journal)
01:30AM	Press Release: Availability of the Q3 2023 Memorandum for modelling purposes (GlobeNewswire)
Sep-21-23 01:34PM	Sanofi CEO: How AI may ease the pressure of Medicare price negotiations (Yahoo Finance)
01:34PM	Sanofi CEO Paul Hudson: All in on AI (Yahoo Finance)
Sep-20-23 12:42PM	AI helping speed up the timeline to create new drugs: Sanofi CEO (Yahoo Finance Video)
Sep-19-23 03:04PM	3 Stocks to Buy to Ride Europes Coming Market Surge (InvestorPlace)
11:01AM	UPDATE 2-Moderna to cut mRNA drug substance production at Lonza facility (Reuters)
02:30AM	Press Release: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change (GlobeNewswire)
08:00AM	Loading…
Sep-14-23 08:00AM	'Transformative Event' For First Wave BioPharma: License Agreement for Hopeful Gastrointestinal Candidate From Sanofi (Benzinga)
07:45AM	This Market Could Be Worth $10 Billion by 2030 -- 2 Stocks to Buy Now (Motley Fool)
06:00AM	First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi (GlobeNewswire)
Sep-13-23 08:15AM	Sanofi and rapper/actor Ice-T unveil trailer for The Season as a warning against the flu (PR Newswire)
Sep-11-23 02:02PM	Sanofi: Information concerning the total number of voting rights and shares - August 2023 (GlobeNewswire)
Sep-01-23 09:09AM	The Zacks Analyst Blog Highlights Oracle, Abbott Laboratories, Sanofi, Realty Income and Hilton Worldwide Holdings (Zacks)
Aug-31-23 02:08PM	Top Stock Reports for Oracle, Abbott & Sanofi (Zacks)
11:45AM	Why Sanofi (SNY) is a Top Dividend Stock for Your Portfolio (Zacks)
11:31AM	Why Is Merck (MRK) Up 4.3% Since Last Earnings Report? (Zacks)
11:16AM	UPDATE 1-US senators push drugmakers for details on low-cost insulin programs (Reuters)
09:40AM	Why Sanofi (SNY) is a Top Value Stock for the Long-Term (Zacks)
07:00AM	US senators push drugmakers for details on low-cost insulin programs (Reuters)
06:15AM	The Petri Dish: Boston Scientific device succeeds in trial, Sanofi vet joins Flagship (American City Business Journals)
01:30AM	Press Release: Sanofi announces changes to its Executive Committee (GlobeNewswire)
Aug-26-23 10:20AM	Ken Fishers Top 15 Healthcare Stock Picks (Insider Monkey)
10:49AM	Loading…
Aug-21-23 10:49AM	11 Most Profitable Biotech Stocks Today (Insider Monkey)
Aug-18-23 10:00AM	2 Biotech Stocks That Could Make You Richer (Motley Fool)
Aug-16-23 08:50AM	Amazon Pharmacy will offer $35 insulin as price cuts continue throughout the industry (Yahoo Finance)
Aug-15-23 03:24PM	Sanofi: Information concerning the total number of voting rights and shares - July 2023 (GlobeNewswire)
Aug-14-23 11:19AM	MacroGenics' (MGNX) Shares Jump 19% in One Week: Here's Why (Zacks)
05:10AM	2 Top Biotech Stocks to Buy Right Now (Motley Fool)
Aug-11-23 12:05PM	15 Most Important Medical Discoveries in History (Insider Monkey)
Aug-10-23 12:33PM	Why Shares of MacroGenics Are Jumping Thursday (Motley Fool)
Aug-04-23 09:59AM	CDC Recommends New Sanofi, AstraZeneca Shot to Prevent RSV in Babies (Barrons.com)
Aug-03-23 03:21PM	Press Release: U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus (nirsevimab-alip) to protect infants against RSV disease (GlobeNewswire)
12:53PM	Regeneron (REGN) Q2 Earnings & Sales Top, Eylea Sales Decline (Zacks)
06:45AM	UPDATE 1-Regeneron Pharma beats profit estimates on Dupixent demand (Reuters)
Aug-02-23 08:39PM	The Petri Dish: Alexion buys Pfizer gene therapies in $1B deal; Peter Hecht's plan to save Cyclerion assets (American City Business Journals)
Jul-30-23 07:45AM	The Top Healthcare Stocks to Buy With $100 (Motley Fool)
Jul-28-23 04:00PM	Sanofi (SNY) Q2 2023 Earnings Call Transcript (Motley Fool)
03:48PM	Analyst Report: Sanofi (Morningstar Research)
12:42PM	Regeneron (REGN) to Report Q2 Earnings: What's in Store? (Zacks)
12:24PM	iPhone US Shipments Take A Hit, Does Social Media Algorithm Impact Political Beliefs? Research Reveals Answer, Disney Joins Netflix To Crack Down Password Sharing In India: Today's Top Stories (Benzinga)
11:32AM	Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III (Zacks)
11:20AM	Sanofi (SNY) Beats on Q2 Earnings, Misses Sales, Stock Down (Zacks)
07:22AM	Press release: Online availability of Sanofis half-year financial report for 2023 (GlobeNewswire)
05:06AM	Sanofi: Q2 Earnings Snapshot (AP Finance)
05:05AM	UPDATE 2-European shares slip overall but German blue-chips hit record high (Reuters)
03:01AM	European shares dip on mixed earnings, higher yields (Reuters)
02:15AM	UPDATE 1-Sanofi lifts earnings outlook on new drug launches, Dupixent sales (Reuters)
01:42AM	Sanofi lifts earnings outlook on new drug launches, Dupixent sales (Reuters)
01:32AM	Press Release: Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healthy aging segment (GlobeNewswire)
01:30AM	Press Release: Solid Q2 performance and strong pipeline momentum, Full-year 2023 business EPS guidance raised (GlobeNewswire)
Jul-25-23 08:00AM	Sanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact (PR Newswire)
Jul-22-23 05:42AM	20 Countries With The Highest Rate Of Diabetes (Insider Monkey)
Jul-21-23 11:21AM	Pharma Stock Roundup: JNJ, NVS Upbeat Q2 Results, FDA Nod to SNY & AZN RSV Antibody (Zacks)
Jul-20-23 08:00AM	Recludix Pharma Enters into a Strategic Collaboration with Sanofi to Advance Novel Oral STAT6 Inhibitor in Multiple Immunological and Inflammatory Indications (GlobeNewswire)
Jul-18-23 12:29PM	Sanofi: Information concerning the total number of voting rights and shares June 2023 (GlobeNewswire)
11:24AM	Sanofi (SNY), AstraZeneca's RSV Antibody Gets FDA Nod in Infants (Zacks)
11:07AM	AstraZeneca-Sanofi's Respiratory Syncytial Virus Treatment Scores FDA Approval To Prevent Infection In Infants (Benzinga)
Jul-17-23 01:48PM	FDA Approves First RSV Drug to Protect All Infants From Virus (The Wall Street Journal)
01:00PM	Press Release: FDA approves Beyfortus (nirsevimab-alip) to protect infants against RSV disease (GlobeNewswire)
Jul-11-23 11:45AM	This is Why Sanofi (SNY) is a Great Dividend Stock (Zacks)
11:23AM	UPDATE 1-Takeda withdraws US application for dengue vaccine candidate (Reuters)
Jul-05-23 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jun-30-23 05:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Jun-29-23 06:00PM	Analyst Report: Sanofi (Morningstar Research)
01:30AM	Press Release: Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease (GlobeNewswire)
Jun-28-23 05:21PM	Sanofi (SNY) Atopic Dermatitis Drug Meets Goals in Phase II Study (Zacks)
Jun-27-23 06:15PM	Sanofi (SNY) Gains But Lags Market: What You Should Know (Zacks)
09:33AM	Sanofi's Amlitelimab Hits Primary Goal In Mid-Stage Atopic Dermatitis Study (Benzinga)
01:30AM	Press Release: Positive topline Phase 2b data in atopic dermatitis support amlitelimab as a potential first and best-in-class novel investigational anti-OX40-ligand monoclonal antibody (GlobeNewswire)
Jun-25-23 10:30AM	Press Release: ALTUVIIIO late-breaking data at ISTH demonstrates highly effective bleed protection in children with severe hemophilia A with once-weekly dosing (GlobeNewswire)
Jun-23-23 07:55AM	GSK Stock Climbs on Zantac Settlement. Drug Maker Avoids a California Trial. (Barrons.com)
Jun-22-23 01:30PM	European regulator investigates Ozempic, Wegovy maker on thyroid cancer risk (Yahoo Finance)
01:30AM	Press Release: Availability of the Q2 2023 Memorandum for modelling purposes (GlobeNewswire)
Jun-21-23 12:58PM	Analyst Report: Sanofi SA (Argus Research)
12:43PM	Market Update: SNY, EXPE, EXPE (Argus Research)
11:45AM	Sanofi (SNY) Could Be a Great Choice (Zacks)
Jun-20-23 01:43PM	Sanofi: Information concerning the total number of voting rights and shares - May 2023 (GlobeNewswire)
12:44PM	UPDATE 2-China-exposed miners, luxury shares drag STOXX 600 down; Lanxess plunges (Reuters)
11:07AM	Spotify to Launch New Expensive Subscription Plan, Chinese Vendors Bypass US Embargo to Supply Nvidia AI Chips, Eddie Wu To Succeed Daniel Zhang As Alibaba's CEO: Today's Top Stories (Benzinga)
08:41AM	2 Biopharma Stocks Making Big Moves Tuesday (Motley Fool)
04:17AM	CORRECTED-UPDATE 1-German shares lead losses in Europe as Lanxess plunges (Reuters)
02:57AM	Sanofi says arbitration court rejects Boehringer's Zantac claims (Reuters)
01:30AM	Press Release: Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim (GlobeNewswire)
Jun-16-23 10:07AM	2 Best Biotech Stocks to Buy Right Now (Motley Fool)
Jun-14-23 06:15PM	Sanofi (SNY) Outpaces Stock Market Gains: What You Should Know (Zacks)
Jun-13-23 08:00AM	Press Release: Sanofi all in on artificial intelligence and data science to speed breakthroughs for patients (GlobeNewswire)
06:04AM	15 Most Profitable Drugs In The World (Insider Monkey)
Jun-12-23 03:00AM	The First Vaccines for RSV Are Coming Soon. What to Know. (Barrons.com)
Jun-09-23 01:43PM	FDA Panel Endorses AstraZeneca (AZN), Sanofi's RSV Antibody (Zacks)
10:41AM	Innate (IPHA) Gains as Blood Cancer Drug Gets Fast Track Tag (Zacks)
10:07AM	Unanimous Support for AstraZeneca and Sanofi's Nirsevimab: Next Generation RSV Treatment on the Horizon (Benzinga)
Jun-08-23 06:15PM	Sanofi (SNY) Outpaces Stock Market Gains: What You Should Know (Zacks)

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SNY | Sanofi ADR

Upgrade your FINVIZ experience